Global and United States DTaP and Tdap Vaccines Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global DTaP and Tdap Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The DTaP and Tdap Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
DTaP and Tdap Vaccines market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, DTaP and Tdap Vaccines market has been segmented into DTaP, Td, Tdap, etc.
Breakdown by Application, DTaP and Tdap Vaccines has been segmented into Adult, Pediatric, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global DTaP and Tdap Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level DTaP and Tdap Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global DTaP and Tdap Vaccines market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and DTaP and Tdap Vaccines Market Share Analysis
DTaP and Tdap Vaccines competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, DTaP and Tdap Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the DTaP and Tdap Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in DTaP and Tdap Vaccines are: Sanofi Pasteur, Pfizer Inc, Novartis AG, GlaxoSmithKline, Astellas Pharma US, Inc, Protein Sciences Corporation, Lanzhou Institute of Biological Products Co., Ltd, Merck Sharp & Dohme Corp, Seqirus, Johnson & Johnson, AstraZeneca, Emergent BioSolutions Inc, etc. Among other players domestic and global, DTaP and Tdap Vaccines market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global DTaP and Tdap Vaccines market are listed below:
Sanofi Pasteur
Pfizer Inc
Novartis AG
GlaxoSmithKline
Astellas Pharma US, Inc
Protein Sciences Corporation
Lanzhou Institute of Biological Products Co., Ltd
Merck Sharp & Dohme Corp
Seqirus
Johnson & Johnson
AstraZeneca
Emergent BioSolutions Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
DTaP
Td
Tdap
Market segment by Application, can be divided into
Adult
Pediatric
Table of Contents
1 Market Overview
1.1 DTaP and Tdap Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DTaP and Tdap Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market Analysis by Application
1.3.1 Overview: Global DTaP and Tdap Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult
1.3.3 Pediatric
1.4 Global DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
1.4.1 Global DTaP and Tdap Vaccines Revenue and Forecast (2015-2025)
1.4.2 Global DTaP and Tdap Vaccines Sales and Forecast (2015-2025)
1.5 Global DTaP and Tdap Vaccines Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi Pasteur SWOT Analysis
2.1.4 Sanofi Pasteur Product and Services
2.1.5 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer Inc SWOT Analysis
2.2.4 Pfizer Inc Product and Services
2.2.5 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Astellas Pharma US, Inc
2.5.1 Astellas Pharma US, Inc Details
2.5.2 Astellas Pharma US, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Astellas Pharma US, Inc SWOT Analysis
2.5.4 Astellas Pharma US, Inc Product and Services
2.5.5 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Protein Sciences Corporation
2.6.1 Protein Sciences Corporation Details
2.6.2 Protein Sciences Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Protein Sciences Corporation SWOT Analysis
2.6.4 Protein Sciences Corporation Product and Services
2.6.5 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lanzhou Institute of Biological Products Co., Ltd
2.7.1 Lanzhou Institute of Biological Products Co., Ltd Details
2.7.2 Lanzhou Institute of Biological Products Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lanzhou Institute of Biological Products Co., Ltd SWOT Analysis
2.7.4 Lanzhou Institute of Biological Products Co., Ltd Product and Services
2.7.5 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck Sharp & Dohme Corp
2.8.1 Merck Sharp & Dohme Corp Details
2.8.2 Merck Sharp & Dohme Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck Sharp & Dohme Corp SWOT Analysis
2.8.4 Merck Sharp & Dohme Corp Product and Services
2.8.5 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Seqirus
2.9.1 Seqirus Details
2.9.2 Seqirus Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Seqirus SWOT Analysis
2.9.4 Seqirus Product and Services
2.9.5 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson SWOT Analysis
2.10.4 Johnson & Johnson Product and Services
2.10.5 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 AstraZeneca SWOT Analysis
2.11.4 AstraZeneca Product and Services
2.11.5 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Emergent BioSolutions Inc
2.12.1 Emergent BioSolutions Inc Details
2.12.2 Emergent BioSolutions Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Emergent BioSolutions Inc SWOT Analysis
2.12.4 Emergent BioSolutions Inc Product and Services
2.12.5 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global DTaP and Tdap Vaccines Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global DTaP and Tdap Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global DTaP and Tdap Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players DTaP and Tdap Vaccines Sales in United States (2018-2019)
3.2.2 United States DTaP and Tdap Vaccines Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 DTaP and Tdap Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 DTaP and Tdap Vaccines Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global DTaP and Tdap Vaccines Market Size by Geography (2015-2020)
4.1.1 Global DTaP and Tdap Vaccines Sales by Geography (2015-2020)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Regions (2015-2020)
4.2 Global DTaP and Tdap Vaccines Market Size and Forecast by Regions (2020-2025)
4.2.1 Global DTaP and Tdap Vaccines Sales and Forecast by Regions (2020-2025)
4.2.2 Global DTaP and Tdap Vaccines Revenue and Forecast by Regions (2020-2025)
4.3 North America DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
4.4 Europe DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
4.5 Asia-Pacific DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
4.6 South America DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
4.7 Middle East and Africa DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America DTaP and Tdap Vaccines Market Size by Country (2015-2020)
5.1.1 North America DTaP and Tdap Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America DTaP and Tdap Vaccines Revenue and Market Share by Country (2015-2020)
5.2 North America DTaP and Tdap Vaccines Market Size and Forecast by Country (2020-2025)
5.2.1 North America DTaP and Tdap Vaccines Sales and Forecast by Country (2020-2025)
5.2.2 North America DTaP and Tdap Vaccines Revenue and Forecast by Country (2020-2025)
5.3 United States DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
5.4 Canada DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
5.5 Mexico DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe DTaP and Tdap Vaccines Market Size by Country (2015-2020)
6.1.1 Europe DTaP and Tdap Vaccines Sales by Country (2015-2020)
6.1.2 Europe DTaP and Tdap Vaccines Revenue by Country (2015-2020)
6.2 Europe DTaP and Tdap Vaccines Market Size and Forecast by Country (2020-2025)
6.2.1 Europe DTaP and Tdap Vaccines Sales and Forecast by Country (2020-2025)
6.2.2 Europe DTaP and Tdap Vaccines Revenue and Forecast by Country (2020-2025)
6.3 Germany DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
6.4 United Kingdom DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
6.5 France DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
6.6 Russia DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
6.7 Italy DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific DTaP and Tdap Vaccines Market Size by Region (2015-2020)
7.1.1 Asia-Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020)
7.1.2 Asia-Pacific DTaP and Tdap Vaccines Revenue by Region (2015-2020)
7.2 Asia-Pacific DTaP and Tdap Vaccines Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific DTaP and Tdap Vaccines Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific DTaP and Tdap Vaccines Revenue and Forecast by Region (2020-2025)
7.3 China DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7.4 Japan DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7.5 Korea DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7.6 India DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7.7 Southeast Asia DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
7.8 Australia DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America DTaP and Tdap Vaccines Market Size by Country (2015-2020)
8.1.1 South America DTaP and Tdap Vaccines Sales by Country (2015-2020)
8.1.2 South America DTaP and Tdap Vaccines Revenue by Country (2015-2020)
8.2 South America DTaP and Tdap Vaccines Market Size and Forecast by Country (2020-2025)
8.2.1 South America DTaP and Tdap Vaccines Sales and Forecast by Country (2020-2025)
8.2.2 South America DTaP and Tdap Vaccines Revenue and Forecast by Country (2020-2025)
8.3 Brazil DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
8.4 Argentina DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa DTaP and Tdap Vaccines Market Size by Country (2015-2020)
9.1.1 Middle East & Africa DTaP and Tdap Vaccines Sales by Country (2015-2020)
9.1.2 Middle East & Africa DTaP and Tdap Vaccines Revenue by Country (2015-2020)
9.2 Middle East & Africa DTaP and Tdap Vaccines Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa DTaP and Tdap Vaccines Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa DTaP and Tdap Vaccines Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
9.4 Turkey DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
9.5 Egypt DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
9.6 South Africa DTaP and Tdap Vaccines Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global DTaP and Tdap Vaccines Market Size by Type (2015-2020)
10.1.1 Global DTaP and Tdap Vaccines Sales by Type (2015-2020)
10.1.2 Global DTaP and Tdap Vaccines Revenue by Type (2015-2020)
10.1.3 Global DTaP and Tdap Vaccines Price by Type (2015-2020)
10.2 Global DTaP and Tdap Vaccines Market Size and Forecast by Type (2020-2025)
10.2.1 Global DTaP and Tdap Vaccines Sales and Forecast by Type (2020-2025)
10.2.2 Global DTaP and Tdap Vaccines Revenue and Forecast by Type (2020-2025)
10.2.3 Global DTaP and Tdap Vaccines Price and Forecast by Type (2020-2025)
10.3 United States DTaP and Tdap Vaccines Market Size and Forecast by Type (2015-2025)
10.3.1 United States DTaP and Tdap Vaccines Market Size by Type (2015-2020)
10.3.2 United States DTaP and Tdap Vaccines Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global DTaP and Tdap Vaccines Market Size by Application (2015-2020)
11.1.1 Global DTaP and Tdap Vaccines Sales by Application (2015-2020)
11.1.2 Global DTaP and Tdap Vaccines Revenue by Application (2015-2020)
11.1.3 Global DTaP and Tdap Vaccines Price by Application (2015-2020)
11.2 Global DTaP and Tdap Vaccines Market Size and Forecast by Application (2020-2025)
11.2.1 Global DTaP and Tdap Vaccines Sales and Forecast by Application (2020-2025)
11.2.2 Global DTaP and Tdap Vaccines Revenue and Forecast by Application (2020-2025)
11.2.3 Global DTaP and Tdap Vaccines Price and Forecast by Application (2020-2025)
11.3 United States DTaP and Tdap Vaccines Market Size and Forecast by Application (2015-2025)
11.3.1 United States DTaP and Tdap Vaccines Market Size by Application (2015-2020)
11.3.2 United States DTaP and Tdap Vaccines Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global DTaP and Tdap Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global DTaP and Tdap Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global DTaP and Tdap Vaccines Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Pasteur DTaP and Tdap Vaccines Major Business
Table 7. Sanofi Pasteur DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 8. Sanofi Pasteur SWOT Analysis
Table 9. Sanofi Pasteur DTaP and Tdap Vaccines Product and Services
Table 10. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc DTaP and Tdap Vaccines Major Business
Table 13. Pfizer Inc DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer Inc SWOT Analysis
Table 15. Pfizer Inc DTaP and Tdap Vaccines Product and Services
Table 16. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 18. Novartis AG DTaP and Tdap Vaccines Major Business
Table 19. Novartis AG DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 20. Novartis AG SWOT Analysis
Table 21. Novartis AG DTaP and Tdap Vaccines Product and Services
Table 22. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline DTaP and Tdap Vaccines Major Business
Table 25. GlaxoSmithKline DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline DTaP and Tdap Vaccines Product and Services
Table 28. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Astellas Pharma US, Inc Basic Information, Manufacturing Base and Competitors
Table 30. Astellas Pharma US, Inc DTaP and Tdap Vaccines Major Business
Table 31. Astellas Pharma US, Inc DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 32. Astellas Pharma US, Inc SWOT Analysis
Table 33. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product and Services
Table 34. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Protein Sciences Corporation DTaP and Tdap Vaccines Major Business
Table 37. Protein Sciences Corporation DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 38. Protein Sciences Corporation SWOT Analysis
Table 39. Protein Sciences Corporation DTaP and Tdap Vaccines Product and Services
Table 40. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 42. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Major Business
Table 43. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 44. Lanzhou Institute of Biological Products Co., Ltd SWOT Analysis
Table 45. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product and Services
Table 46. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 48. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Major Business
Table 49. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 50. Merck Sharp & Dohme Corp SWOT Analysis
Table 51. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product and Services
Table 52. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Seqirus Basic Information, Manufacturing Base and Competitors
Table 54. Seqirus DTaP and Tdap Vaccines Major Business
Table 55. Seqirus DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 56. Seqirus SWOT Analysis
Table 57. Seqirus DTaP and Tdap Vaccines Product and Services
Table 58. Seqirus DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 60. Johnson & Johnson DTaP and Tdap Vaccines Major Business
Table 61. Johnson & Johnson DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 62. Johnson & Johnson SWOT Analysis
Table 63. Johnson & Johnson DTaP and Tdap Vaccines Product and Services
Table 64. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 66. AstraZeneca DTaP and Tdap Vaccines Major Business
Table 67. AstraZeneca DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 68. AstraZeneca SWOT Analysis
Table 69. AstraZeneca DTaP and Tdap Vaccines Product and Services
Table 70. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Emergent BioSolutions Inc Basic Information, Manufacturing Base and Competitors
Table 72. Emergent BioSolutions Inc DTaP and Tdap Vaccines Major Business
Table 73. Emergent BioSolutions Inc DTaP and Tdap Vaccines Total Revenue (USD Million) (2018-2019)
Table 74. Emergent BioSolutions Inc SWOT Analysis
Table 75. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product and Services
Table 76. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Global DTaP and Tdap Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 78. Global DTaP and Tdap Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 79. Key Players DTaP and Tdap Vaccines Sales in United States (2018-2019) (K Units)
Table 80. Key Players DTaP and Tdap Vaccines Sales Market Share in United States (2018-2019)
Table 81. Key Players Revenue of DTaP and Tdap Vaccines in United States (2018-2019) (USD Million)
Table 82. Global DTaP and Tdap Vaccines Sales by Regions (2015-2020) (K Units)
Table 83. Global DTaP and Tdap Vaccines Sales Market Share by Regions (2015-2020)
Table 84. Global DTaP and Tdap Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 85. Global DTaP and Tdap Vaccines Sales and Forecast by Regions (2020-2025) (K Units)
Table 86. Global DTaP and Tdap Vaccines Sales Market Share by Regions (2020-2025)
Table 87. Global DTaP and Tdap Vaccines Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 88. Global DTaP and Tdap Vaccines Revenue Market Share by Regions (2020-2025) (USD Million)
Table 89. North America DTaP and Tdap Vaccines Sales by Countries (2015-2020) (K Units)
Table 90. North America DTaP and Tdap Vaccines Sales Market Share by Countries (2015-2020)
Table 91. North America DTaP and Tdap Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 92. North America DTaP and Tdap Vaccines Revenue Market Share by Countries (2015-2020)
Table 93. North America DTaP and Tdap Vaccines Sales by Country (2020-2025) (K Units)
Table 94. North America DTaP and Tdap Vaccines Sales Market Share by Country (2020-2025)
Table 95. North America DTaP and Tdap Vaccines Revenue by Country (2020-2025) (USD Million)
Table 96. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2020-2025)
Table 97. Europe DTaP and Tdap Vaccines Sales by Countries (2015-2020) (K Units)
Table 98. Europe DTaP and Tdap Vaccines Sales Market Share by Countries (2015-2020)
Table 99. Europe DTaP and Tdap Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 100. Europe DTaP and Tdap Vaccines Revenue Market Share by Countries (2015-2020)
Table 101. Europe DTaP and Tdap Vaccines Sales by Country (2020-2025) (K Units)
Table 102. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2020-2025)
Table 103. Europe DTaP and Tdap Vaccines Revenue by Country (2020-2025) (USD Million)
Table 104. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2020-2025)
Table 105. Asia-Pacific DTaP and Tdap Vaccines Sales by Countries (2015-2020) (K Units)
Table 106. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Countries (2015-2020)
Table 107. Asia-Pacific DTaP and Tdap Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 108. Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Countries (2015-2020)
Table 109. Asia-Pacific DTaP and Tdap Vaccines Sales by Country (2020-2025) (K Units)
Table 110. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Country (2020-2025)
Table 111. Asia-Pacific DTaP and Tdap Vaccines Revenue by Country (2020-2025) (USD Million)
Table 112. Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Country (2020-2025)
Table 113. South America DTaP and Tdap Vaccines Sales by Countries (2015-2020) (K Units)
Table 114. South America DTaP and Tdap Vaccines Sales Market Share by Countries (2015-2020)
Table 115. South America DTaP and Tdap Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 116. South America DTaP and Tdap Vaccines Revenue Market Share by Countries (2015-2020)
Table 117. South America DTaP and Tdap Vaccines Sales by Country (2020-2025) (K Units)
Table 118. South America DTaP and Tdap Vaccines Sales Market Share by Country (2020-2025)
Table 119. South America DTaP and Tdap Vaccines Revenue by Country (2020-2025) (USD Million)
Table 120. South America DTaP and Tdap Vaccines Revenue Market Share by Country (2020-2025)
Table 121. Middle East & Africa DTaP and Tdap Vaccines Sales by Countries (2015-2020) (K Units)
Table 122. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Countries (2015-2020)
Table 123. Middle East & Africa DTaP and Tdap Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 124. Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share by Countries (2015-2020)
Table 125. Middle East & Africa DTaP and Tdap Vaccines Sales by Country (2020-2025) (K Units)
Table 126. Middle East & Africa DTaP and Tdap Vaccines Sales Market Share by Country (2020-2025)
Table 127. Middle East & Africa DTaP and Tdap Vaccines Revenue by Country (2020-2025) (USD Million)
Table 128. Middle East & Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2020-2025)
Table 129. United States DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 130. United States DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 131. United States DTaP and Tdap Vaccines Revenue by Type (2015-2020) (USD Million)
Table 132. United States DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
Table 133. United States DTaP and Tdap Vaccines Sales by Type (2020-2025) (K Units)
Table 134. United States DTaP and Tdap Vaccines Sales Market Share by Type (2020-2025)
Table 135. United States DTaP and Tdap Vaccines Revenue by Type (2020-2025) (USD Million)
Table 136. United States DTaP and Tdap Vaccines Revenue Market Share by Type (2020-2025)
Table 137. Global DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 138. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 139. Global DTaP and Tdap Vaccines Revenue by Application (2015-2020) (USD Million)
Table 140. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
Table 141. Global DTaP and Tdap Vaccines Price by Application (2015-2020) (USD/Unit)
Table 142. Global DTaP and Tdap Vaccines Sales by Application (2020-2025) (K Units)
Table 143. Global DTaP and Tdap Vaccines Sales Market Share by Application (2020-2025)
Table 144. Global DTaP and Tdap Vaccines Revenue by Application (2020-2025) (USD Million)
Table 145. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2020-2025)
Table 146. Global DTaP and Tdap Vaccines Price by Application (2020-2025) (USD/Unit)
Table 147. United States DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 148. United States DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 149. United States DTaP and Tdap Vaccines Revenue by Application (2015-2020) (USD Million)
Table 150. United States DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
Table 151. United States DTaP and Tdap Vaccines Sales by Application (2020-2025) (K Units)
Table 152. United States DTaP and Tdap Vaccines Sales Market Share by Application (2020-2025)
Table 153. United States DTaP and Tdap Vaccines Revenue by Application (2020-2025) (USD Million)
Table 154. United States DTaP and Tdap Vaccines Revenue Market Share by Application (2020-2025)
Table 155. Direct Channel Pros & Cons
Table 156. Indirect Channel Pros & Cons
Table 157. Distributors/Traders/ Dealers List
Table 158. Customers of DTaP and Tdap Vaccines
Table 159. Market Opportunities in Next Few Years
Table 160. Market Risks Analysis
Table 161. Market Drivers
List of Figures
Figure 1. DTaP and Tdap Vaccines Picture
Figure 2. Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. DTaP Picture
Figure 4. Td Picture
Figure 5. Tdap Picture
Figure 6. DTaP and Tdap Vaccines Sales Market Share by Application in 2019
Figure 7. Adult Picture
Figure 8. Pediatric Picture
Figure 9. Global DTaP and Tdap Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global DTaP and Tdap Vaccines Sales Growth Rate (2015-2025) (K Units)
Figure 11. Global DTaP and Tdap Vaccines Sales Market Share by Manufacturer in 2019
Figure 12. Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players DTaP and Tdap Vaccines Revenue Market Share in United States in 2019
Figure 14. Global Top 5 DTaP and Tdap Vaccines Manufacturer Market Share in 2019
Figure 15. Top 3 DTaP and Tdap Vaccines Players Market Share in United States in 2019
Figure 16. Global DTaP and Tdap Vaccines Revenue Market Share by Regions in 2019
Figure 17. North America DTaP and Tdap Vaccines Sales YoY Growth (2015-2025) (K Units)
Figure 18. North America DTaP and Tdap Vaccines Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe DTaP and Tdap Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 20. Europe DTaP and Tdap Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific DTaP and Tdap Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 22. Asia-Pacific DTaP and Tdap Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America DTaP and Tdap Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 24. South America DTaP and Tdap Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa DTaP and Tdap Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 26. Middle East & Africa DTaP and Tdap Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 28. North America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 29. United States DTaP and Tdap Vaccines Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada DTaP and Tdap Vaccines Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico DTaP and Tdap Vaccines Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 33. Germany DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific DTaP and Tdap Vaccines Sales Market Share by Region 2018
Figure 39. Asia-Pacific DTaP and Tdap Vaccines Revenue Market Share by Region 2018
Figure 40. China DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 47. South America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 48. Brazil DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa DTaP and Tdap Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of DTaP and Tdap Vaccines by Type in 2019
Figure 55. Global Revenue Market Share of DTaP and Tdap Vaccines by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Sanofi Pasteur
Pfizer Inc
Novartis AG
GlaxoSmithKline
Astellas Pharma US, Inc
Protein Sciences Corporation
Lanzhou Institute of Biological Products Co., Ltd
Merck Sharp & Dohme Corp
Seqirus
Johnson & Johnson
AstraZeneca
Emergent BioSolutions Inc
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets